by Janncike Kristoffersen | Oct 21, 2024
Researchers and clinicians at Haukeland University Hospital, the University of Bergen, and the University of Oslo have developed a new method to predict mood-states change in people with bipolar disorder using artificial intelligence. A patent application for the...
by Janncike Kristoffersen | Jun 28, 2024
Researchers Victor Greiff and Fridtjof Lund-Johansen from the University of Oslo and Oslo University Hospital, respectively, have entered a research collaboration with the Danish biotech company Genmab. The aim of the collaboration, according to them, is to explore...
by Janncike Kristoffersen | Jan 5, 2024
Inven2 is grateful to everyone who has contributed to building business and helping patients through new inventions, clarification, clinical studies, and commercial results. When someone is willing to pay for products, services, and values created when knowledge is...
by Janncike Kristoffersen | Nov 28, 2023
The Nordic Life Science Days is the largest partnering conference for life sciences in the Nordic countries. Inven2 will participate with a joint Norwegian stand and in meetings with the industry to promote innovation projects from our portfolio. Feel free to contact...
by Janncike Kristoffersen | Sep 19, 2023
This summer, the U.S.-based biotechnology company Mage Biologics Inc (“Mage Bio”) was formed as a collaboration between the Swiss specialty pharma company Tillotts Pharma and the international venture capital firm TVM Capital Life Science. Up to USD 28 million will be...
by Elisabeth Kirkeng Andersen | Mar 21, 2023
The platform company Authera, spun out of research at the University of Oslo and Oslo University Hospital, reports that they have entered into a collaborative agreement with one of Europe’s hottest biotechnology companies: argenx. Authera has had a flying start...
